Influenza hemagglutinin antigenic distance measures capture trends in HAI differences and infection outcomes, but are not suitable predictive tools

Jan 1, 2020·
Amanda Skarlupka
Amanda Skarlupka
,
Andreas Handel
,
Ted M. Ross
· 0 min read
Type
Publication
Vaccine
publications
Amanda Skarlupka
Authors
Senior Program Manager at Vivli
I’m an infectious disease and data scientist advancing public health through ethical, FAIR, and impactful data sharing. At Vivli, I lead member engagement and strategic planning for the Antimicrobial Resistance (AMR) Register and serve as a subject matter expert in data governance and international data sharing. My work bridges researchers, clinicians, and data scientists to drive innovation in health equity, AI ethics, and open science.